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Abstract: The impact of omega-3 long-chain polyunsaturated fatty acids (LCPUFAs) on cognition
is heavily debated. In the current study, the possible association between omega-3 LCPUFAs
in blood and cognitive performance of 266 typically developing adolescents aged 13–15 years is
investigated. Baseline data from Food2Learn, a double-blind and randomized placebo controlled
krill oil supplementation trial in typically developing adolescents, were used for the current study.
The Omega-3 Index was determined with blood from a finger prick. At baseline, participants
finished a neuropsychological test battery consisting of the Letter Digit Substitution Test (LDST),
D2 test of attention, Digit Span Forward and Backward, Concept Shifting Test and Stroop test.
Data were analyzed with multiple regression analyses with correction for covariates. The average
Omega-3 Index was 3.83% (SD 0.60). Regression analyses between the Omega-3 Index and the
outcome parameters revealed significant associations with scores on two of the nine parameters.
The association between the Omega-3 Index and both scores on the LDST (β = 0.136 and p = 0.039),
and the number of errors of omission on the D2 (β = ´0.053 and p = 0.007). This is a possible
indication for a higher information processing speed and less impulsivity in those with a higher
Omega-3 Index.
Keywords: docosahexaneoic acid (DHA); eicosapentaenoic acid (EPA); adolescents; cognition;
Omega-3 fatty acids; Omega-3 Index
1. Introduction
In recent decades, an increasing interest in the health benefits of long-chain polyunsaturated
fatty acids (LCPUFAs) has been developed. Aside from its influence on cardiovascular health, it has
also attracted attention because of its association with mental health (ADHD, autism, dyslexia) [1],
cognitive functioning of healthy individuals [2–4] and cognitive decline in the elderly [5–7].
LCPUFAs and especially docosahexaneoic acid, 22:6n-3 (DHA), and eicosapentaenoic acid 20:5n-3
(EPA) are involved in many aspects of brain functioning such as neuronal membrane fluidity,
neurotransmission, signal transduction, brain blood flow, and blood-brain barrier integrity [8,9].
The interest in the possible positive influence of LCPUFAs on brain functioning has led to a large
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number of both observational and experimental studies (for a review see [10,11]). These studies have,
however, mainly focused on either diseased populations of infants, children, adults, and the elderly.
Studies in typically developing adolescents are limited. The current study addresses this deficit.
Adolescence is a period in which LCPUFAs could be of special importance. During adolescence,
the brain, especially the prefrontal cortex, undergoes development which continues until after
age 20 [12,13]. The development of the prefrontal cortex is of utmost importance, since this
development lays the basis for higher order cognitive functions that have been associated with
academic achievements [14]. Moreover, the prefrontal cortex is a brain region especially enriched
in DHA [15], and higher DHA intake has been associated with changes in the functional activity of
the prefrontal cortex in boys aged 8–10 [16].
To our knowledge, three observational studies looking at the association between fish intake
(the most important source of omega-3 LCPUFAs) and cognitive functioning in adolescents have
been executed. Kim and colleagues showed that adolescents aged 15 years who regularly consumed
fish had significantly better academic performance than peers who never or hardly ever consumed
fish [17]. Aberg et al. demonstrated that high fish consumption in boys at age 15 was associated
with better cognitive performance at age 18 [18]. Lastly, de Groot et al. studied 700 Dutch high
school students aged 12–18 years. Fish consumption data, end term grades in Dutch, English and
Math, scores on the Amsterdam Vocabulary Test, and scores on the Youth Self-Report (a self-reported
measure for attention problems) were collected [19]. Results revealed that 13.6% of the Dutch
adolescents never ate fish, 63.1% ate fish but too little to meet at least half of the recommended
amount, 16.9% reached half of the recommended amount, and 6.4% met national guidelines
(fish twice per week). Analysis of the variance showed significant differences between the four
fish consumption groups (never, <1 per week (e.g., 1 time per month), 1 to 2 times per week,
ě2 times per week) in vocabulary, and a trend for significance was found for the average end term
grade. Significant quadratic associations (u-shape association) between fish consumption, vocabulary
(p = 0.01), and average end term grades (p = 0.001) were shown. Higher fish intake was associated
with a more advanced vocabulary and an almost significantly higher average end term grade.
However, eating more fish than the recommended amount (>2 fish portions/week) seemed to no
longer be beneficial. Overall, the observational studies in adolescents point to a beneficial association
between fish intake (the main source of the omega-3 LCPUFAs DHA and EPA) and school grades.
Fish consumption is the most important dietary source of LCPUFAs but not the only source [20].
Moreover, there is a large interpersonal variability in the uptake of LCPUFAs [21]. Thus, to be sure
about the association between LCPUFAs and cognition in adolescents, measurement of LCPUFAs in
blood is needed. Therefore, the main objective of this study is to investigate the association between
the Omega-3 Index (EPA + DHA in erythrocytes as percentage of total fatty acids measured [22])
measured in blood and cognitive performance in typically developing adolescents of lower general
secondary education (LGSE). Cognition is a very broad term that includes both lower order
simple responses and higher order processes. The higher order processes are also called the
executive functions, and it is generally agreed that there are three core executive functions namely:
(i) inhibition and interference; (ii) working memory; and (iii) cognitive flexibility [23]. These executive
functions are used to build higher order skills such as reasoning and problem solving. Therefore,
the executive functions are important for academic success and cognitive development [23]. These
executive functions are located in the prefrontal cortex, the brain area most in development
during adolescence [24]. The cognitive tasks used in the current study are standard tasks of
cognitive/executive functioning for this age group and have previously been shown to increase
activation of the frontal cortex, the area of the brain associated with the accumulation of DHA [16].
In addition to the main objective, two sub-objectives will be addressed. A number of earlier
studies have shown differences in the LCPUFA status between typically developing participants and
participants with disorders such as ADHD, autism, and dyslexia [25,26]. However, to our knowledge,
whether LCPUFAs are associated with cognition in participants with learning disorders differently
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than in those without learning disorders has not yet been assessed. The second objective of the current
study is, therefore, to explore whether the association between the Omega-3 Index and cognitive
ability is different between adolescents with and without learning disorders.
Social economic status, often operationalized as educational level, has been shown to be
associated with diet quality (i.e., people with a higher SES have better diet quality) [27]. Moreover,
in adults, higher social economic status has been found to be associated with higher fish
consumption [28]. However, even though it is known that students from lower general secondary
education (LSGE) levels have a less healthy diet and lifestyle than students from the higher levels [29],
how much fish students from the LSGE consume has, to our knowledge, not yet been assessed.
Therefore, the third objective of this study is to explore the fish consumption of second year students
of the LSGE.
2. Materials and Methods
2.1. Design
This study was part of a larger randomized controlled clinical trial (Food2Learn) studying
the influence of omega-3 LCPUFA supplementation on cognitive performance, mental wellbeing,
and academic achievement scores in adolescents attending LGSE. Baseline data of Food2Learn were
used to study the association between the Omega-3 Index measured in whole blood and cognition.
Food2Learn has been approved by the Medical Ethical Committee of Atrium-Orbis-Zuyd Hospital
(now Zuyderland), Heerlen, The Netherlands (NL45803.096.13). Food2Learn has been registered
at the Netherlands Trial Register (NTR4082), which is connected to Clinicaltrials.gov (registered
as NCT02240264.)
2.2. Procedure and Participants
Participants were recruited from 17 schools in the south of the Netherlands. For students who
wanted to participate, an informed consent form had to be signed by themselves as well as by
both parents and/or guardians. After informed consent was received, students underwent a finger
prick to measure their Omega-3 Index. Inclusion criteria for Food2Learn were: 1 Omega-3 Index
<5%, as it was expected that omega-3 fatty acid supplementation will be especially beneficial for
participants with a very low baseline Omega-3 Index [22]; and 2 attending the second year of LSGE
because Richardson et al. showed that omega-3 supplementation was especially beneficial in the 20%
lowest performing students [30]. Therefore, the choice for students at one of the lowest educational
levels in The Netherland’s LGSE was made. In the Netherlands, secondary education is divided
into three levels: pre-university, higher general secondary education, and LGSE. Approximately
38% of all adolescents follow LGSE [31]. LGSE is further divided up into four sublevels. For this
study, students from the highest sublevel, the theoretical learning pathway (TLP), were recruited.
Approximately 40% of students attending LGSE are in the TLP [31]. No other inclusion criteria were
applied, thus, all second year students of the LSGE with an Omega-3 Index <5% could participate.
After inclusion, participants underwent a neuropsychological test battery in a small group setting
(10 students max) consisting of: Letter Digit Substitution Task (LDST), D2 test of Attention (D2),
Digit Span Forward (DSF), and Backward (DSB). In addition, they filled out a number of
questionnaires to collect important background information. The tests were led by one researcher
via a standardized protocol, while one or two other researchers (depending on the group size) were
monitoring to ensure that participants understood the tests and complied with the protocol. Before
continuing with the real tests, students received a practice version of the tests, feedback was given,
and the students confirmed they understood the tests. After this group test session, all participants
filled out a questionnaire individually (data not used in the current study), during which participants
were called one by one to perform the individual neuropsychological tests: Stroop Test and Concept
Shifting Test (CST) under the supervision of one researcher.
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2.3. Dependent Variable—Blood Analysis
Whole blood was obtained from a finger prick with an automated lancet and directly
transferred to a filter paper (Whatman 903, General Electric, Frankfurt, Germany) pre-treated with
a stabilizer. Filter papers were shipped immediately to Omegametrix, Martinsried, Germany for
analysis. Whole blood fatty acid compositions were analyzed according to the HS-Omega-3 Index
methodology [32]. Fatty acid methyl esters are generated by acid transesterification and analyzed by
gas chromatography using a GC2010 Gas Chromatograph (Shimadzu, Duisburg, Germany) equipped
with a SP2560, 100-m column (Supelco, Bellefonte, PA, USA) using hydrogen as a carrier gas. Fatty
acids are identified by comparison with a standard mixture of fatty acids. Results are given as EPA
plus DHA expressed as a percentage of total identified fatty acids after response factor correction.
Since the Omega-3 Index is defined as EPA + DHA in erythrocytes, it was calculated using a sliding
correction factor. The coefficient of variation for EPA plus DHA typically is 5%. Analyses are
quality-controlled according to DIN ISO 15189.
2.3.1. Independent Variables—Cognitive Measures
The LDST is a paper-pencil task used to measure speed of information processing [33]. A nine
letter/digit key is noted at the top of a page. Below this key, rows of letters are printed,
and participants are asked to write the corresponding number in the box underneath the letter as
quickly as possible. The number of correctly filled in numbers in 60 s is used as a measure of speed
of information processing.
2.3.2. D2 Test of Attention
The D2 test is a paper-pencil task used to measure selective attention [34]. Participants are
presented with 14 rows each consisting of 47 stimuli. Stimuli are the letters d and p with a varying
number of dashes (between 1 and 4), below, above, or on both sides. Participants are instructed to
only cross out the d with two dashes (2 above, 2 below or one on both sides) and ignore all other
stimuli. Participants have to process as many stimuli as possible in 20 s per line after which they
have to continue with the next row without pausing. The following measures per row and in total
are noted after completion: total number of stimuli processed, number of correctly crossed out d2’s,
number of d2’s not crossed out, and number of stimuli wrongly crossed out (thus, non d2). The total
number of stimuli processed is used as a measure for information processing speed. The number of
target stimuli not crossed out (i.e., errors of omission) and non-target stimuli crossed out (i.e., errors
of commission) are used as a measure for impulsivity and inattention, respectively.
2.3.3. Digit Span Forward and Backward
The DSF is a measure for short-term memory that primarily activates the phonological loop.
The DSB activates the executive component directly and shows the dynamic relationship between
passive storage and active manipulation or transformation of information held in the memory [35]
and is thus a measure for working memory (the ability to hold information in the mind and work with
it). The DSF consists of 12 sequences of digits varying in length from three to eight digits (each length
twice). Digits are announced by the researcher at a rate of approximately one digit per second. After
completion of the digit sequence, participants are asked to write down the sequence. The DSB is
similar to the DSF, except for the fact that it consists of 12 digit sequences varying in length from two
to seven digits (each length twice) and after completion of the sequence by the researcher, students are
asked to write down the sequence backwards, starting with the last number announced. The longest
sequence of numbers of which participants had correctly written down at least one of the two rows
was used as a measure for working memory.
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2.3.4. Concept Shifting Task
The CST is a measure for cognitive shifting [36]. Cognitive shifting is the ability to adapt to
changes in the environment by switching from one mental set to another [33]. The task consists of
four parts. All parts consist of a sheet of paper with 16 small circles grouped in one large circle. In task
A, the small circles are randomly filled with numbers, in task B the circles are filled with letters, and in
task C the circles are filled with both. Participants are asked to cross out the items in the correct order
(A: 1 to 12; B: A to P; C: 1–A–2–B to 8-H). Lastly, there is Task Zero, which consists of empty circles,
where participants are asked to cross out the circles as quickly as possible. Task Zero is administered
twice, and the average of these times is used to correct for basic motor speed in the other tasks. For all
tasks, the time taken to complete and the number of errors are noted. The average of motor-speed
corrected time needed for A and B was subtracted from the motor speed corrected time needed for C
and used as a measure for shifting.
2.3.5. Stroop Test
The Stroop test provides a measure for cognitive inhibition. Cognitive inhibition is the ability
to inhibit an overlearned response in favor of a more unusual one [37]. The Stroop task, as used
in Food2Learn, consists of three cards containing 40 stimuli each: color names printed in black
(Task 1), colored patches (Task 2), and color names printed in congruent or incongruent color (Task 3).
For Task 1, participants are asked to read the name out loud. For Task 2, participants name the color of
the patches, and for Task 3, participants name the ink color the word is printed in. Task 3 is a measure
of mental flexibility and the ability to inhibit a dominant response (reading). The time needed for
Task 2 was subtracted from the time needed for Task 1, the result of this sum was subtracted from the
time needed for Task 3. The result of this sum was used as a measure for inhibition.
2.3.6. Additional Measures
Students filled out a questionnaire to assess covariates. The following covariates were assessed
as they are known to correlate with cognition: BMI (weight/length2, self-reported) [36], sex [37],
age [38], alcohol consumption [39], smoking [40], and parental level of education [41]. Alcohol
consumption was assessed with two questions: the number of days/week the participant generally
drank alcohol and the number of units the participant drinks on a day that (s)he drinks alcohol.
Alcohol consumption was defined as the number of alcohol units/time multiplied by the number
of drinking days/week, and the measurement was used as a continuous measure. Smoking was
assessed with the question: “How many cigarettes do you smoke per week?”. If the participant
indicated consuming cigarettes, (s)he was classified as smoker. Parental level of education was
filled out by the parents on an ordinal eight-point scale [42]. Parental level of education was
defined as the parent with the highest level of education, which is an indication for social economic
status [43]. Additionally, fish consumption was assessed with a short, validated, and self-reported
questionnaire [3]. Different kinds of fish were divided based on their DHA content: low (fish fingers,
prawns, pickled herring, cod, mussels, plaice, tuna, tilapia); medium (trout, raw herring, smoked eel,
smoked salmon, canned salmon); and high (smoked herring, herring and tomato sauce, mackerel,
canned sardines, salmon). The consumption (never, once a month, two to three times a month, once
a week or more than once a week) was used to calculate the fish consumption score. For the low
DHA fish 0, 1, 2, 4, 8 points; for the medium DHA fish, 0, 2, 4, 8, 16 points; and for the high DHA
fish, 0, 3, 6, 12, 24 points. The score for fish consumption could thus vary between 0 and 48 points.
Lastly students were asked to indicate whether they had a disorder which could influence learning
(examples were given) and who had made that diagnosis.
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2.4. Quality Control
To ensure the quality of the data, all tests were scored by two independent researchers.
Any discrepancies were solved by discussion. Furthermore, in order to prevent typing mistakes,
all data were entered in the database twice, after which the two files were automatically compared.
Any discrepancies between the two data files were checked and corrected by a third researcher.
2.5. Statistical Analyses
Data were checked for normality and if necessary, transformation was applied. Data were
analyzed with linear regression or generalized linear regression (Poisson) for count data and data
with a skewed distribution. For all analyses, first, a model with all covariates (i.e., smoking, alcohol
consumption units per week), BMI, age, level of parental education, sex, and diagnosis) was built;
Model A. In Model B, the Omega-3 Index was added. In a separate analysis, potential moderation
between the Omega-3 Index and diagnosis was tested. If results were significant, a sub-group analysis
for typically developing adolescents and those who had indicated to have some sort of learning
disorder (autism, dyslexia, ADHD, etc.) were executed in the same way (diagnosis was not entered
as a covariate). For all analyses, a p-value below 0.05 was considered to be significant. All analyses
were carried out using SPSS statistics version 22.
3. Results
3.1. Participants
A total of 286 students consented to participate in the study. Of these, four dropped out before
blood sampling due to personal reasons and 16 had an Omega-3 Index > 5%. Thus, the associations
between the Omega-3 Index and cognition of 266 participants (127 boys, 139 girls; Mage = 14.1 years)
are discussed in this paper. Characteristics of the participants can be found in Table 1. Omega-3
Index and LCPUFAs as determined in blood can be found in Table 2. Scores on the cognitive tests
can be found in Table 3. In this sample, 69 participants indicated having a disorder which can impact
learning; 14 indicated having Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit
Disorder (ADD); 45 indicated having dyslexia or dyscalculia; eight reported an autism spectrum
disorder; and two indicated a depression. In the total sample of 266 adolescents, 13.8% indicated
never consuming fish, 77% indicated eating fish very irregularly (i.e., less than half of the recommend
amount of 450 mg DHA + EPA per day), 8.4% consumed at least half of the recommended amount
(once a week), and 1% indicated consuming fish more than once a week. There was a significant
difference in fish consumption between boys and girls (p = 0.024), with boys consuming more fish
than girls. However, this did not result in significant differences in the Omega-3 Index (p = 0.561).
The total score on the fish questionnaire correlated significantly with both the Omega-3 Index
(n = 216, r = 0.294, p < 0.001) and DHA concentration (n = 216, r = 0.287, p < 0.001).
3.2. Cognitive Performance
Analyses revealed a significant association between the Omega-3 Index and score on the LDST
(β = 0.136, p = 0.039). The addition of the Omega-3 Index to the model increased the r2 with 0.017
(Table 4), i.e., an additional 1.7% of the variance was explained. Furthermore, a significant association
between the Omega-3 Index and errors of omission on the D2 was shown (β = ´0.053, p = 0.007)
(Table 5). The analysis for errors of omission also showed a significant moderator effect (p = 0.005).
No other significant associations between the Omega-3 Index and any of the other cognitive measures
were found.
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Table 1. Participant characteristics.
Characteristic
All Participants With Diagnosis 1 Without Diagnosis 2
p-Value 5Mean ˘ SD
or N (%) N
Mean ˘ SD
or N (%) N
Mean ˘ SD
or N (%) N
Age (years) 14.10 ˘ 0.49 266 14.26 ˘ 0.51 69 14.05 ˘ 0.47 196 0.002
Male/Female 127/139(47.7/52.3%) 266
36/33
(52.2/47.8%) 69
93/103
(47.5/52.5%) 196 0.499
Smoking no/yes 3
239/26
(90.2/9.8%) 265
59/10
(85.5/14.5%) 69
179/16
(91.8/8.2%) 195 0.132
Body Mass Index (BMI) 19.92 ˘ 3.00 248 20.34 ˘ 3.61 65 19.77 ˘ 2.74 183 0.187
Alcohol units per week 4 0.46 ˘ 1.77 266 0.69 ˘ 2.85 69 0.39 ˘ 1.19 196 0.218
Level of Parental
Education (LPE) 5.07 ˘ 1.52 248 5.21 ˘ 1.40 66 5.02 ˘ 1.56 182 0.371
1 Diagnosis was defined as a diagnosis possible to influence learning; this was indicated by students
themselves and included (but not limited to) dyslexia, dyscalculia, depression, autism, and Attention Deficit
Hyperactivity Disorder (ADHD); 2 without diagnosis was defined as all students who did not indicate to have
a diagnosis; 3 smoking was defined as anybody who indicated to smoke more than 0 cigarettes per week;
4 alcohol units per week was operationalized as number of day per week that alcohol is consumed times
units per consumption moment; 5 comparison between those with and those without diagnoses. ANOVA was
used for age, BMI, LPE and alcohol units per week, Chi Square for smoking, and sex. Significant differences
(p < 0.05) are noted in bold.
Table 2. Fatty acid blood.
Fatty Acid
(% wt/wt of Total FA)
All Participants With Diagnosis 1 Without Diagnosis 2
p-Value 3N = 261 N = 68 N = 193
Mean ˘ SD Mean ˘ SD Mean ˘ SD
Omega-3 Index 3.83 ˘ 0.60 3.79 ˘ 0.61 3.84 ˘ 0.60 0.537
DHA 22:6n-3 2.58 ˘ 0.49 2.56 ˘ 0.50 2.59 ˘ 0.49 0.667
EPA 20:5n-3 0.39 ˘ 0.16 0.38 ˘ 0.13 0.39 ˘ 0.16 0.356
AA 20:4n-6 11.19 ˘ 1.25 11.49 ˘ 1.34 11.08 ˘ 1.20 0.022
ObA 22:5n-3 0.43 ˘ 0.10 0.43 ˘ 0.11 0.44 ˘ 0.10 0.725
1 Diagnosis was defined as a diagnosis possible to influence learning; this was indicated by students
themselves and included (but not limited to) dyslexia, dyscalculia, depression, autism and ADHD; 2 without
diagnosis was defined as all students who did not indicate to have a diagnosis; 3 Comparison between those
with and those without diagnoses. Significant differences (p < 0.05) are noted in bold. DHA: docosahexaneoic
acid; EPA: eicosapentaenoic acid.
Table 3. Scores on the cognitive tests.
Measures
All Participants With Diagnosis 1 Without Diagnosis 2
p-Value 3N = 261 N = 68 N = 196
Mean ˘ SD Mean ˘ SD Mean ˘ SD
LDST (number) 34.47 ˘ 5.46 33.52 ˘ 6.51 34.80 ˘ 5.02 0.094
D2-correct (number) 163.13 ˘ 22.95 160.04 ˘ 24.24 164.22 ˘ 22.45 0.194
D-error of omission (number) 11.83 ˘ 10.73 11.25 ˘ 8.07 12.04 ˘ 11.53 0.598
D2-error of commission (number) 1.31 ˘ 10.73 1.54 ˘ 1.96 1.22 ˘ 1.43 0.161
D2-Total (number) 417.33 ˘ 56.46 408.93 ˘ 55.11 420.29 ˘ 56.77 0.151
Shifting score (s) 11.70 ˘ 6.83 11.69 ˘ 6.50 11.71 ˘ 6.96 0.980
Inhibition score (s) 31.35 ˘ 8.50 34.85 ˘ 9.19 30.12 ˘ 7.91 0.000
Digit span Forward (digits) 5.58 ˘ 0.88 5.26 ˘ 0.87 5.70 ˘ 0.85 0.616
Digit Span Backward (digits) 4.56 ˘ 0.98 4.51 ˘ 0.93 4.58 ˘ 1.00 0.000
1 Diagnosis was defined as a diagnosis possible to influence learning; this was indicated by students
themselves and included (but not limited to) dyslexia, dyscalculia, depression, autism, and ADHD; 2 without
diagnosis was defined as all students who did not indicate to have a diagnosis; 3 Comparison between those
with and those without diagnoses. Significant differences (p < 0.05) are noted in bold.
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Table 4. Results of multiple linear regression analyses between the Omega-3 Index and score on the
Letter Digit Substitution Test (LDST) in the complete sample.
Predictor Variable B (Standardized) 1 Significance 2
Model A (r2 = 0.058, df = 7, p = 0.051)
Smoking 0.028 0.679
Alcohol consumption 0.031 0.649
BMI 0.089 0.171
Age 0.047 0.477
Sex 0.177 0.007
Highest LPE ´0.056 0.387
Diagnosis ´0.104 0.113
Model B (r2 = 0.075, df = 8, p = 0.019)
Smoking 0.031 0.643
Alcohol consumption 0.045 0.500
BMI 0.080 0.218
Age 0.036 0.584
Sex 0.172 0.008
Highest LPE 3 ´0.084 0.203
Diagnosis ´0.094 0.147
Omega-3 Index 0.136 0.039
1 Standardized beta refers to how many standard deviations the dependent variable will change per standard
deviation change in the predictor variable. Smoking, sex, and diagnosis were not standardized as they are
dichotomous variables; 2 Significant results (p < 0.05) are printed in bold; 3 LPE = level of parental education.
Table 5. Results of generalized linear model analyses between the Omega-3 Index and number of
errors of omission on the D2 test in the complete sample.
Predictor Variable B (Standardized) 1 Significance 2
Model A (χ2 = 47.90, df = 7, p < 0.001)
Smoking 0.066 0.310
Alcohol consumption 0.036 0.030
BMI 0.043 0.026
Age 0.036 0.068
Sex ´0.047 0.226
Highest LPE ´0.087 0.000
Diagnosis ´0.071 0.109
Model B (χ2 = 51.852, df = 8, p < 0.001)
Smoking 0.062 0.349
Alcohol consumption 0.030 0.078
BMI 0.043 0.028
Age 0.041 0.037
Sex ´0.052 0.181
Highest LPE 3 ´0.077 0.000
Diagnosis ´0.083 0.063
Omega-3 Index ´0.053 0.007
1 Standardized beta refers to how many standard deviations the dependent variable will change per standard
deviation change in the predictor variable. Smoking, sex, and diagnosis were not standardized as they are
dichotomous variables; 2 Significant results (p < 0.05) are printed in bold; 3 LPE = level of parental education.
3.3. Sub-Group Analyses
When participants were divided into those without learning disorders and those who indicated
having one or more learning disorders, differences between the two groups arose. Those with a
diagnosis were significantly older (Table 1, p = 0.002, 14.26˘ 0.51, and 14.05˘ 0.47, respectively) than
those without a diagnosis. Furthermore, they had a slightly higher AA status (Table 2, 11.08 ˘ 1.20,
and 11.49 ˘ 1.34, respectively). With regard to the test scores, there was a significant difference in
average score between those with and those without a diagnoses in inhibition as measured with the
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Stroop test (p = 0.000, 34.85 ˘ 9.19, and 30.12 ˘ 7.91, respectively) and on the digit span backwards
(p = 0.000, 5.26 ˘ 0.869, and 5.7 ˘ 0.851, respectively).
When a moderation term was added to the regression analysis, a moderation effect was seen for
the number of errors of omission (p = 0.005), i.e., the association between the Omega-3 Index and score
on the D2—the errors of omission were different between those with and those without diagnosis.
Therefore, a separate group regression analysis was executed. This analysis showed no significant
associations in adolescents with one or more learning disorders between the Omega-3 Index and
errors of omission (p = 0.073). For typically developing adolescents, a significant association between
the Omega-3 Index and errors of omission was seen (Table 6), students with a higher Omega-3 Index
had a lower number of errors.
Table 6. Results of generalized linear model analyses between the Omega-3 Index and number of
errors of omission on the D2 test in the typically developing participant sample.
Predictor Variable B (Standardized) 1 Significance 2
Model A (χ2 = 42.11, df = 6, p < 0.001)
Smoking 0.032 0.685
Alcohol consumption 0.036 0.277
BMI 0.091 0.000
Age 0.002 0.914
Sex ´0.136 0.003
Highest LPE ´0.085 0.000
Model B (χ2 = 55.642, df = 7, p < 0.001)
Smoking 0.029 0.714
Alcohol consumption 0.027 0.410
BMI 0.089 0.000
Age 0.015 0.515
Sex ´0.138 0.002
Highest LPE 3 ´0.067 0.003
Omega-3 Index ´0.083 0.000
1 Standardized beta refers to how many standard deviations the dependent variable will change per standard
deviation change in the predictor variable. Smoking and sex were not standardized as they are dichotomous
variables; 2 Significant results (p < 0.05) are printed in bold; 3 LPE = level of parental education.
4. Discussion
The main aim of this study was to investigate the association between the Omega-3 Index
measured in blood and cognitive performance of 14-year-old Dutch adolescents. The Omega-3
Index was significantly associated with information processing operationalized as LDST score. This
indicates that a higher Omega-3 Index was associated with better information processing speeds.
Every 1% increase in the Omega-3 Index was associated with an increase of 1.23 digits on the
LDST. Also, students with a higher Omega-3 Index had fewer errors of omission on the D2 test of
attention, an indicator of inattention/impulsivity (i.e., they paid more attention than students with a
lower Omega-3 Index). An increase of 1% in the Omega-3 Index was associated with a decrease of
0.94 stimuli forgotten to cross out. Associations with all other cognitive measures were not significant.
To our knowledge, this is the first study assessing the association between the Omega-3 Index
measured in blood and cognition in typically developing adolescents from the general population.
There are a number of observational studies of adolescents that found positive associations between
fish consumption, the most important source of omega-3 LCPUFAs, and school grades [17–19].
However, even though cognition/executive functioning and school performance are correlated,
they are not equal. School performance depends on additional factors such as time spent on
homework [44] and personality [45]. Although we are not aware of studies looking at the
association/relationship between LCPUFA status and cognition in adolescents, multiple studies of
children are available. For example, Portillo-Reyes et al. found an improvement in processing
Nutrients 2016, 8, 13 10 of 14
speed in their supplementation study (180 mg DHA and 270 mg EPA per day for three months)
of marginally malnourished children age 8–12 years [46]. Parletta et al. also found a positive effect
of supplementation (750 mg EPA + DHA per school day for 40 weeks) on a non-verbal cognitive
test [47]. However, there are also a number of studies that do not show an association or relationship
between omega-3 LCPUFAs and cognition in children [48–50]. Overall, results remain mixed, and a
number of possible explanations for these differences have been proposed [50,51]. For example, it has
been suggested that an effect of LCPUFAs on cognition might be more likely to be demonstrated in
underperforming children and adolescents, as shown in the study of Richardson et al. [30]. We tried
to address this in the current study by recruiting students from one of the lowest educational levels
in the Netherlands. Additionally, it has been suggested that LCPUFAs might only be beneficial in
certain periods of life when the brain is developing, the so-called windows of opportunity. We tried
to address this by including adolescents because the brain undergoes profound development in
adolescence [12].
A number of earlier studies have shown a positive relationship between LCPUFAs and cognition
in people with learning disorders [30,52–54]. Therefore, a moderator analysis was executed to check
whether the association between the Omega-3 Index and score on the cognitive test was different
between those with and those without a learning disorder. If a moderator effect was shown, separate
analyses for adolescents who indicated to have a learning disorder versus typically developing
adolescents were executed. There was a significant association between the covariate diagnosis and
score on errors of commission and on the interference score. The moderator effect could, however,
only be shown for errors of omission. Firstly, the number of students with a diagnosis was relatively
low (n = 69), which could have led to a reduced statistical power. Secondly, the self-reporting of
diagnosis and the fact that many adolescents did not know who made the diagnosis could have led
to attenuation of the associations. Thus, the measure of diagnosis might not be accurate. However,
when the test scores of those with and those without a diagnosis were compared, students with a
diagnosis score lower on the test of interference (Stroop). This would suggest that the assessment
of a learning disorder is accurate, since it has been shown before that patients with ADHD and
other psychiatric problems have impaired performance on this test [55]. Moreover, the variation
in the Omega-3 Index (inherent to our pre-selection of participants with an Omega-3 Index < 5%)
was relatively low (SD = 0.61), which makes the appearance of associations less likely. In contrast,
even though this spread was also low (SD = 0.60) in typically developing adolescents, a significant
association between Omega-3 Index and cognitive measures could be shown. This could be explained
by the fact that the number of students with a diagnosis was only 69; therefore, the power to detect
an association was not sufficient [56].
The Omega-3 Index (3.83%) in this sample was relatively low (well below the recommended
range of 8%–11% [22]). This could be due to the exclusion of participants with a high Omega-3 Index,
although if these were included the mean was still only 3.89 (SD 0.67). The low Omega-3 Index in
this sample is no surprise since 13.9% of the students did not consume any fish and 77% consumed
fish rarely, as measured by the fish consumption questionnaire. This frequency of fish consumption
is somewhat lower than the consumption of the adolescents in the sample of de Groot et al. [19].
However, the study of de Groot et al. was carried out with students in higher general secondary
education or pre-university education with a somewhat higher social economic status (assessed by
level of education of the parents) than the students in the current study. The number of students
that never consume fish is also in line with the results from the National Dutch Consumption Survey,
which indicates that 11% of boys and 18% of girls never consume fish [57]. Similarly in our sample,
girls also consumed significantly less fish than boys. However, the number of adolescents who
consumed fish twice or more a week was in only 1% in this sample, while in the survey 9% of the
boys and 7% of the girls consumed the recommended amount of fish.
The main strength of the current study is that the Omega-3 Index was measured in blood.
Furthermore, standardized and validated cognitive tests that assess several aspects of executive
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functioning were used. The main limitation of the study is that it is an observational study
and can, therefore, not prove causality. Also, the variation in the Omega-3 Index was rather
small. Furthermore, no Bonferroni correction for multiple statistical was applied, with correction
significant results were not present anymore, which weakens the certainty of the associations found.
However, the data presented here are part of a large intervention study, which will elucidate the
effect of LCPUFA supplementation on cognition, mood, and academic achievement in adolescence.
Furthermore, the supplementation study will achieve a higher Omega-3 Index and a larger spread
in the Omega-3 Index, which could lead to more significant results (a number of associations were
borderline significant).
In conclusion, this study has revealed a positive association between the Omega-3 Index
measured in blood from typically developing adolescents and two of the nine cognitive measures.
The results of the supplementation study will further elucidate the effect of LCPUFA supplementation
on cognition. If a positive effect of LCPUFA supplementation on cognition is shown, this could help
improve cognitive functioning and possibly the school performance of adolescents in a relatively
inexpensive and easy way.
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